Hrt Financial LP Inmune Bio, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$10.53 - $14.01 $314,825 - $418,870
29,898 New
29,898 $351,000
Q2 2021

Aug 16, 2021
SELL
$9.29 - $19.33 $204,890 - $426,323
-22,055 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$11.61 - $26.85 $256,058 - $592,176
22,055 New
22,055 $262,000

Others Institutions Holding INMB

# of Institutions
71
Shares Held
5.92M
Call Options Held
243K
Put Options Held
46.4K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $79.3M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email